Orgenesis Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ORGS Company Description
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
ORGS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ORGS Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ORGS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ORGS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ORGS in WallStreetBets Daily Discussion
ORGS News
Recent insights relating to ORGS
CNBC Recommendations
Recent picks made for ORGS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ORGS
Corporate Flights
Flights by private jets registered to ORGS
Our Analysis